PubMed HealthSearch

PubMed · 8484247

Taiwan Blood Donation Program: a model for development.

Abstract

In 1974, the Taiwan National Blood Program had not yet been fully developed. The volunteer donor base was less than 5% and there was no organized national structure or regulation of blood services. Following the founding of the Blood Donation Association and the Blood Services Foundation, promotion of an all-volunteer blood program, increased utilization of blood components and the standardization of laboratory methods were strategies that led to the development of the Taiwan National Blood Program. In 1991, 1,066,082 units of blood were collected in Taiwan, serving a population of about 20 million. There are currently 6 major blood centers and 13 blood stations. Blood donation is now 100% volunteer and 78% of all blood collected is separated into 10 available components. With national organization and regulation, the transition has taken 17 years and has resulted in a community-based, all-volunteer blood supply.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

S J Tsai, T D Lee. 1993. Taiwan Blood Donation Program: a model for development.. https://doi.org/10.1111/j.1423-0410.1993.tb05154.x

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Clinical-grade functional dendritic cells from patients with multiple myeloma are not infected with Kaposi's sarcoma-associated herpesvirus.

Bone marrow dendritic cells (DC) from patients with multiple myeloma (MM) were recently reported to be infected with Kaposi's sarcoma-associated herpesvirus (KSHV). Because immunotherapy strategies using DC are very promising in this disease, we looked for KSHV DNA in clinical-grade DC generated in vitro from MM patients. Adherent apheresis cells from MM patients were maintained for 7 days in clinical-grade X-VIVO 15 culture medium supplemented with granulocyte-macrophage colony-stimulating factor, interleukin-4, or interleukin-13. Tumor necrosis factor alpha was added for the last 2 days. We obtained a cell population with a DC phenotype able to endocytose fluorescein isothiocyanate (FITC)-dextran and efficiently activate resting allogenic T lymphocytes. To detect KSHV DNA, we used polymerase chain reaction (PCR) followed by Southern blotting of PCR product with a sensitivity detecting a few copies of viral DNA. All the PCR were repeated in a blinded fashion three times, on 1 mug and 0.2 mug of genomic DNA, in two different laboratories. Clinical-grade DC from 10 (91%) of 11 patients were not infected with KSHV. The apheresis cells and the purified CD34(+) cells from the same patients were also negative. A very weak PCR band was detected with DC from one patient, but the initial apheresis cells were negative. The detection of KSHV infection in 1 (9%) of 11 MM patients probably represents background seroprevalence. It seems likely that functional and clinical-grade DC from MM patients can safely be used in clinical trials.

Blood Component Removal

IgA content of washed red blood cell concentrates.

Saline-washed red blood cell (RBC) concentrates are largely depleted of leukocytes, microaggregates, and nearly of all plasma originally contained in the blood unit. Our aim was to determine the concentration of the eliminated IgA and total protein in the buffy coat and plasma removed RBC concentrate before and after a sequential dilution-centrifugation washing procedure, 75.3% protein, and 99% IgA were eliminated by the washing process used. The recovery of red blood cells was 87.2%. Our results have led to the conclusion that two sequential washings seem to guarantee an IgA level of less than 0.2 mg/unit to meet the recommendations of the Council of Europe. Additional advantages of washing include low levels of extracellular hemoglobin, metabolic waste products and debris in the supernatant.

Blood Component Removal